Interactions between antiepileptic drugs and psychotropic drugs;Interaktionen zwischen Antiepileptika und Psychopharmaka

Zeitschrift fur Epileptologie

Volumn 19, Issue 2, 2006, Pages 95-108

  Brandt, Christian ^a   Pohlmann Eden, Bernd ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

Author keywords

Antidepressants; Antiepileptic drugs; Epilepsy; Interactions; Neuroleptics

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BROMPERIDOL; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOZAPINE; CYTOCHROME P450; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PHENOBARBITAL; PHENOTHIAZINE; PHENYTOIN; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TOPIRAMATE; TRANYLCYPROMINE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VILOXAZINE; ZIPRASIDONE;

AREA UNDER THE CURVE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; EPILEPSY; HUMAN; MENTAL DISEASE; PRESCRIPTION; TREATMENT OUTCOME;

EID: 33646139890     PISSN: 16176782     EISSN: 16100646     Source Type: Journal    
DOI: 10.1007/s10309-006-0185-1     Document Type: Article

References (138)

1. Andersen BB, Mikkelsen M, Vesterager A, Dam M, Kristensen HB, Pedersen B, Lund J, Mengel H (1991) No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy res 10:201-204
2. Behar D, Schaller J, Spreat S (1998) Extreme reduction of methylphenidate levels by carbamazepine. J Am Acad Child Adolesc Psychiatry 37:1128-1129
3. Bergemann N, Frick A, Parzer P, Kopitz J (2004) Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients. Pharmacopsychiatry 37:63-68
4. Berigan TR, Harazin J (1999) A sertraline/valproic acid drug interaction. Int J Psychiat Clin Pract 3:287-288
5. Bertoldo M (2002) Valproic acid and risperidone. J Am Acad Child Adolesc Psychiatry 41:632
6. Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S (2004) Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 43:763-780
7. Bocchetta A, Chillotti C, Severino G, Ardau R, Del Zompo M (1997) Carbamazepine augmentation in lithiumrefractory bipolar patients: A prospective study on long-term prophylactic effectiveness. J Clin Psychopharmacol 17:92-96
8. Bonnet P, Vandel S, Nezelof S, Sechter D, Bizouard P (1992) Carbamazepine, fluvoxamine: Is there a pharmacodynamic interaction? Therapie 47:165-167
9. Braithwaite RA, Flanagan RJ (1975) Steady-state plasma nortriptyline concentrations in epileptic patients. Brit J Clin Pharmacol 2:469-471
10. Brøsen K. Kragh-Sørensen P. (1993) Concomitant intake of nortriptyline and carbamazepine. Ther Drug Monit 15:258-260
11. Brown CS, Wells BG, Cold JA, Froemming JH, Self TH, Jabbour JT (1990) Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol 10:359-362
12. Burstein AH, Horton RL, Dunn T, Alfaro RM, Piscitelli SC, Theodore W (2000) Lack of effect of St John's wort on carbamazepine pharmacokinetics in healthy volunteers. Clinical Pharmacology & Therapeutics 68:605-612
13. Chaudhry RP, Waters BGH (1983) Lithium and carbamazepine interaction: possible neurotoxicity. J Clin Psychiatry 44:30-31
14. Chen C, Veronese L, Yin Y (2000) The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol 50:193-195
15. Chengappa KN, Gershon S, Levine J (2001) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3:215-232
16. Conca A, Beraus W, König P, Waschgler R (2000) A case of pharmacokinetic interference in comedication of clozapine and valproic acid. Pharmacopsychiatry 33:234-235
17. Costello LE, Suppes T (1995) A clinically significant interaction between clozapine and valproate. J Clin Psychopharmacol 15:139-141
18. Darley J (1994) Interaction between phenytoin and fluoxetine. Seizure 3:151-152
19. De Toledo JC, Haddad H, Ramsay RE (1997) Status epilepticus associated with the combination of valproic acid and clomipramine. Ther Drug Monit 19:71-73
20. Doose DR, Kohl KA, Desai-Krieger D, Natarajan J, van Kammen DP (1999) No clinical significant effect of topiramate on haloperidol plasma concentration. Eur Neuropsychopharmacol 9:S357
21. Dorn JM (1986) A case of phenytoin toxicity possibly precipitated by trazodone. J Clin Psychiatry 47:89-90
22. Dursun SM, Mathew VM, Reveley MA (1993) Toxic serotonin syndrome after fluoxetine plus catbamazepine. Lancet 342:442-443
23. Eap CB, Yasui N, Kaneko S, Baumann P, Powell K, Otani K (1999) Effects of carbamazepine coadministrationon plasma concentrations of of the enantiomers of mianserin and of its metabolites. Ther Drug Monit 21:166-170
24. Ereshefsky L (1996) Drug-drug interactions involving antiedepressants: focus on venlafaxine. Journal clin psychopharmacol 16:37S-50S
25. Facciolá G, Avenoso A, Spina E, Perucca E (1998) Inducing effect of Phenobarbital on clozapine metabolism in patients with chronic schizophrenia. Ther Drug Monit 20:628-630
26. Facciolä G, Avenoso A, Scordo MG, Madia AG, Ventimiglia A, Perucca E, Spina E (1999) Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit 21:341-345
27. Fehr C, Gründer G, Hiemke C, Dahmen N (2000) Increase in serum clomipramine concentrations caused by valproic acid. J Clin Psychopharmacol 20:493-494
28. Finley P, Warner D (1994) Potential impact of valproic acid therapy on clozapine disposition. Biol Psychiatry 36:487-488
29. Fitzgerald BJ, Okos AJ (2002) Elevation of Carbamazepine-10,11-Epoxid by Quetiapine. Pharmacotherapy 22:1500-1503
30. Forrest FM, Forrest IS, Serra MT (1970) Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients. Biological Psychiatry 2:53-58
31. French JA, Gidal BE (2000) Antiepileptic drug interactions. Epilepsia 41, Suppl. 8:S30-S36
32. Fritze J, Unsorg B, Lanczik M (1991) Interaction between carbamazepine and fluvoxamine. Acta Psychiatrica Scandinavica 84:583-584
33. Frye MA, Kimbrell TA, Dunn RT, Piscitelli S, Grothe D, Vanderham E, Cora-Locatelli G, Post RM, Ketter TA (1998) Gabapentin does not alter single-dose lithium pharmacokinetics. J Clin Psychopharmacol 18:461-464
34. Gaitatzis A, Carroll K, Majeed A, W Sander J (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45:1613-1622
35. Gay PE, Madsen JA (1983) Interaction between phenobarbital and thioridazine. Neurology 33:1631-1632
36. Gex-Fabri M, Balant-Gorgia AE, Balant LP (2003) Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking, and comedication. Ther Drug Monit 25:46-53
37. Granneman GR, Schneck DW, Cavanaugh JH, Witt GF (1996) Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. Journal Clin Psychiatry 57:204-206
38. Greb WH, Buscher G, Dierdorf HD, Köster FE, Wolf D, Mellows G (1989) The effect of liver enzyme inhibition by cimetidine and enzyme induction by phenobarbitone on the pharmacokinetics of paroxetine. Acta Psychiatr Scand 80 Suppl. 350:95-98
39. Grimsley SR, Jann MW, Carter JG, D'Mello AP, D'Souza MJ (1991) Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 50:10-15
40. Gross-Tsur V (1999) Carbamazepine and methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry 38:637
41. Haidukewych D, Rodin EA (1985) Effect of phenothiazines on serum antiepileptic drug concentrations in psychiatric patients with seizure disorder. Ther Drug Monit 7:401-404
42. Haselberger MB, Freedman LS, Tolbert S (1997) Elevated serum Phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 17:107-109
43. Hesslinger B, Normann C, Langosch JM, Klose P, Berger M, Walden J (1999) Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. J Clin Psychopharmacol 19:310-315
44. Houghton GW, Richens A (1975) Inhibition of phenytoin metabolism by other drugs used in epilepsy. Int J Clin Pharmacol 12:210-216
45. Ishizaki T, Chiba K, Saito M, Kobayashi K, Iizuka R (1984) The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients. J Clin Psychopharmacol 4:254-261
46. Iwahashi K, Miyatake R, Suwaki H, Hosokawa K, Ichikawa Y (1995) The drug-drug interaction effects of haloperidol on plasma carbamazepine levels. Clin Neuropharmacol 18:233-236
47. Jalil P (1992) Toxic reaction following the combined administration of fluoxetine and phenytoin: Two case reports. JNNP 55:412-413
48. Jerling M, Lindström L, Bondesson U, Bertilsson L (1994) Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: Evidence from a therapeutic drug monitoring service. Ther Drug Monit 16:368-374
49. Jerling M, Bertilsson L, Sjöqvist F (1994) The use of therapeutic drug monitoring data to document kinetic drug interactions: An example with amitriptyline and nortriptyline. Ther Drug Monit 16:1-12
50. Joblin M, Ghose K (1994) Possible interaction of sertraline with carbamazepine. New Zealand Medical Journal 107:43
51. Joffe T, Post RM, Uhde TW (1985) Lack of pharmacokinetic interaction of carbamazepine with tranylcypramine. Archives of General Psychiatry 42:738
52. Joseph AB, Wroblewsky BA (1993) Potentially toxic serum concentrations of desipramine after discontinuation of valproic acid. Brain Injury 7:463-465
53. Kanter GL, Yerewanian Bi, Ciccone JR (1984) Case report of a possible interaction between neuroleptics and carbamazepine. Am J Psychiatry 141:1101-1102
54. Kaufmann, KR Gerner, R (1998) Case report: Lamotrigine toxicity secondary to sertraline. Seizure 7:163-165
55. Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS, Callahan AM, Hinton ML, Chao J, Post RM (1995) Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol 15:327-333
56. Ketter TA, Post RM, Parekh PI, Worthington K (1995) Addition of monoamine oxidase inhibitors to carbamazepine: Preliminary evidence of safety and efficacy in treatment-resistant depression. Journal of Clinical Psychiatry 56:471-475
57. Khan A, Shad MU, Preskorn SH (2000) Lack of sertraline efficacy probably due to an interaction with carbamazepine. J clin psychiatry 61:526-527
58. Kossen M, Selten JP, Kahn RS (2001) Elevated clozapine plasma level with lamotrigine. Am J Psychiatry 158:1930
59. Langbehn DR, Alexander B (2000) Increased risk of side effects in psychiatric patients treated with clozapine and carbamazepine: A reanalysis. Pharmacopsychiatry 33:196
60. Leinonen E, Lillsunde P, Laukkanen V, Ylitalo P (1991) Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients. J Clin Psychopharmacol 11:313-318
61. Leinonen E, Lepola U, Koponen H (1996) Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. Pharmacopsychiatry 29:156-158
62. Licht RW, Olesen OV, Friis P, Laustsen T (2000) Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine. J Clin Psychopharmacol 20:110-112
63. Linnet K, Olesen OV (2002) Free and glucuronidated olanzapine serum concentrations in psychiatric patients: Influence of carbamazepine comedication. Ther Drug Monit 24:512-517
64. Linnoila M, Viukari M, Vaisanen K, Auvinen J (1980) Effect of anticonvulsants on plasma haloperidol and thioridazine levels. American Journal of Psychiatry 137:819-821
65. Loga S, Curry S, Lader M (1975) Interactions of orphenadrine and phenobarbitone with chlorpromazine: Plasma concentrations and effects in man. British Journal of Clinical Pharmacology 2:197-208
66. Lucas RA, Gilfillan DJ, Bergstrom RF (1998) A pharmacokinetic interaction between carbamazepine and olanzapine: Observations on possible mechanism. Eur J Clin Pharmacol 54:639-643
67. Lucena MI, Blanco E, Corrales MA, Berthier ML (1998) Interaction of fluoxetine and valproic acid. Am J Psychiatry 155:575
68. Lydiard RB, White D, Harvey B, Taylor A (1987) Lack of pharmacokinetic interaction between tranylcypromine and carbamazepine. J Clin Psychopharmacol 7:360
69. Madeb R, Hirschmann S, Kurs R, Turkie A, Modai I (2002) Combined clozapine and valproic acid treatment-induced agranulocytosis. Eur Psychiatry 17:238-239
70. Mamiya K, Ieiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, Yamada H, Otsubo K, Higuchi S, Tashiro N (1998) The effects of genetic polymorphism of CYP2C9 and CYP2C19 on Phenytoin metabolism in japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia 39:1317-1323
71. Mamiya K, Kojima K, Yukawa E, Higuchi S, Ieiri I, Ninomiya H, Tashiro N (2001) Phenytoin intoxication induced by fluvoxamine. Ther Drug Monit 23:75-77
72. Markowitz JS, Patrick KS (2001) Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention deficit hyperactivity disorder. Clin Pharmacokinet 40:752-772
73. Markowitz JS, Donovan JI, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD (2003) Effect of St John's wort on drug metabolism by induction of cytochrome P4503A4 enzyme. JAMA 290:1500-1504
74. Martinelli V, Bocchetta A, Palmas AM, Del Zompo M (1993) An interaction between carbamazepine and fluvoxamine. British Journal of Clinical Pharmacology 36:615-616
75. Mayan H, Golubev N, Dinour D, Farvel Z (2001) Lithium intoxication due to carbamazepine-induced renal failure. Ann Pharmacother 35:560-562
76. Miceli JJ, Anziano RJ, Robarge L, Hansen RA, Laurent A (2000) The effect of carbamazepine on the steadystate pharmacokinetics of ziprasidone in healthy volunteers. Brit J Clin Pharmacol 49:65S-70S
77. Miller DD (1991) Effect of Phenytoin on plasma clozapine concentrations in two patients. J Clin Psychiatry 52:23-25
78. Møller SE, Larsen F, Khan AZ, Rolan PE(2001) Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects. J Clin Psychopharmacol 21:493-499
79. Mula M, Monaco F (2002) Carbamazepine-risperidone interactions in patients with epilepsy. Clin Neuropharmacol 25:97-100
80. Muscatello RM, Pacetti M, Cacciola M, La Torre D, Zoccali R, D'Arrigo C, Migliardi G, Spina E (2005) Plasma Concentrations of Risperidone and Olanzapine during Coadministration with Oxcarbazepine. Epilepsia 46:771-774
81. Nawishy S, Hathway N, Turner P (1981) Interactions of anticonvulsant drugs with mianserine and nomifensine. Lancet 8251:871-872
82. Normann C, Hesslinger B, Bauer J, Berger M, Walden J (1998) Die Bedeutung des hepatischen Cytochrom-P450-Systems für die Psychopharmakologie. Nervenarzt 69:944-955
83. Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J (2002) Lamotrigine as adjunct therapy to paroxetine in acute depression: a placebo-controlled, double-blind study. Journal of Clinical Psychiatry 63:337-344
84. Odishaw J, Chen C (2000) Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. Pharmacotherapy 20:1448-1453
85. Odou P, Geronimi-Ferret D, Degen P, Robert H (1996) Viloxazine-carbamazápine: Double interaction dangereuse? A propos d'un cas. Journal de pharmacie clinique 15:157-160
86. Ono S, Mihara K, Suzuki A, Kondo T, Yasuo-Furukori N, Furukori H, de Vries R, Kaneko S (2002) Significant pharmacokinetic interaction between risperidone and carbamazepine: Its relationship with CYP2D6 genotypes. Psychopharmacology 162:50-54
87. Otani K, Ishida M, Yasui N, Kondo T, Mihara K, Suzuki A, Furukori H, Kaneko S, Inoue Y (1997) Interaction between carbamazepine and bromperidol. Eur J Clin Pharmacol 52:219-222
88. Otani K, Ishida M, Kaneko S, Mihara K, Ohkubo T, Osanai T, Sugawara K (1996) Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-Chlorophenylpiperazine. Ther Drug Monit 18:164-167
89. Patsalos PN (2000) Antiepileptic drug pharmacogenetics. Ther Drug Monit 22:127-130
90. Patsalos PN, Froscher W, Pisani F, van Rijn CM (2002) The importance of drug interactions in epilepsy therapy. Epilepsia 43:365-385
91. Patsalos PN, Perucca E (2003) Clinically important drug interactions in epilepsy: General features and interactions between antiepileptic drugs. Lancet Neurol 2:347-356
92. Pearson HJ (1990) Interaction of fluoxetine with carbamazepine. J Clin Psychiatry 51:126
93. Perucca E, Richens A (1977) Interaction between phenytoin and imipramine. British J Clin Pharmacol 4:485-486
94. Pies R (2002) Combining lithium and anticonvulsants in bipolar disorder: a review. Annals of Clinical Psychiatry 14:223-232
95. Pihlsgård M, Eliasson E (2002) Significant reduction of sertralin plasma levels by carbamazepine and phenytoin. Eur J Clin Pharmacol 57:915-916
96. Pinninti NR, Zelinski G (2002) Does topiramate elevate serum lithium levels? J Clin Psychopharmacol 22:340
97. Pisani F, Narbone MC, Fazio A, Crisafulli P, Primerano G, Amendola D'Agostino A, Oteri G, Di Perri R (1984) Effect of viloxazine on serum carbamazepine levels in epileptic patients. Epilepsia 25:482-485
98. Pisani F, Fazio A, Oteri G, Perucca E, Russo M, Trio R, Pisani B, Di Perri R (1986) Carbamazepine-viloxazine interaction in patients with epilepsy. JNNP 49:1142-1145
99. Pisani F, Fazio A, Artesi C, Russo M, Trio R, Oteri G, Perucca E, Di Perri R(1992) Elevation of plasma phenytoin by viloxazine in epileptic patients. JNNP 55:126-127
100. Pisani F, Fazio A, Oteri G, Artesi C, Xiao B, Perucca E, Di Perri R(1994) Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. Acta Neurol Scand 90:130-132
101. Popli AP, Tanquary J, Lamparella V, Masand PS (1995) Bupropion and anticonvulsant drug interactions. Ann Clin Psychiatry 7:99-101
102. Preskorn SH, Alderman J, Greenblatt DJ, Horst WD (1997) Sertraline does not inhibit cytochrome P450 3Amediated drug metabolismin vivo. Psychopharmacology Bulletin 33:659-665
103. Pupeschi G, Agenet C, Levron JC, Barges-Bertocchio MH (1994) Do enzyme inducers modify haloperidol decanoate rate of release? Prog Neuro-Psychopharmacol & Biol Psychiat 18:1323-1332
104. Raitasuo V, Lehtovaara R, Huttunen MO (1993) Carbamazepine and plasma levels of clozapine. Am J Psychiatry 150:169
105. Raitasao V, Lehtovaara R, Huttunen MO (1994) Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report. Psychopharmacology 116:115-116
106. Ranjan S, Jagadheesan K, Nizamie SH (2002) Cerebellar ataxia with intravenous valproate and haloperidol. Australian and New Zealand Journal of Psychiatry 36:268
107. Rapeport WG, Williams SA, Muirhead DC, Dewland PM, Tanner T, Wesnes K (1996) Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 57; Suppl. 1:20-23
108. Rapeport WG, Muirhead DC, Williams SA, Cross M, Wesnes K (1996) Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin. J Clin Psychiatry 57:24-28
109. Reimers A, Skogvoll E, Kutschera J, Spigset O (2005) Drug interactions between lamotrigine and psychoactive drugs: Evidence from a therapeutic drug monitoring service. J Clin Psychopharmacol 25:342-348
110. Sánchez Romero A, Garca Delgado R, Flores Pea M (1999) Interaction between trazodone and carbamazepine. Annals of Pharmacotherapy 33:1370
111. Sands CD, Robinson JD, Salem RB, Stewart RB, Muniz C (1987) Effect of thioridazine on phenytoin serum concentration: A retrospective study. Drug intelligence and clinical pharmacy 21:267-272
112. Shad MU (2004) A complex interaction between clozapine and phenytoin. Journal of Pharmacy Technology 20:280-282
113. Shukla S, Godwin CD, Long LEB, Miller MG (1984) Lithium-Carbamazepine neurotoxicity and risk factors. Am J Psychiatry 141:1604-1606
114. Sitsen JMA, Maris FA, Timmer CJ (2001) Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects. Eur J Drug Metab Pharmacokinet 26:109-121
115. Sovner R, Davis JM (1991) A possible interaction between fluoxetine and valproic acid. J Clin Psychopharmacol 11:389
116. Spaans E, van den Heuvel MW, Schnabel PG, Peters PAM, Chin-Kon-Sung UG, Colbers EPH, Sitsen JMA (2002) Concomitant use of mirtazapine and phenytoin: A drug-drug interaction study in healthy male subjects. Eur J Clin Pharmacol 58:423-429
117. Spina E, Amendola D'Agostino AM, Ioculano MP, Oteri G, Fazio A, Pisani F (1990) No effect of thioridazine on plasma concentrations of carbamazepine and its active metabolite carbamazepine-10,11-epoxide. Ther Drug Monit 12:511-513
118. Spina E, Avenoso A, Pollicino AM, Caputi AP, Fazio A, Pisani F (1993) Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit 15:247-250
119. Spina E, Avenoso A, Campo GM, Caputi AP, Perucca E (1996) Phenobarbital induces the 2-hydroxylation of desipramine. Ther Drug Monit 18:60-64
120. Spina E, Avenoso A, Facciolá G, Salemi M, Scordo MG, Giacobello T, Madia AG, Perucca E (2000) Plasma concentrations of risperidone and 9-hydroyrisperidone: Effect of comedication with carbamazepine or valproate. Ther Drug Monit 22:481-485
121. Spina E, Scordo MG, Avenoso A, Perucca E (2001) Adverse drug interaction between Risperidone and Carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity. J Clin Psychopharmacol 21:108-109
122. Spina E, Perucca E (2002) Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 43, Suppl 2:37-44
123. Spina E, Scordo MG, D'Arrigo C (2003) Metabolic drug interactions with new psychotropic drugs. Fundam Clin Pharmacol 17:517-538
124. Steinacher L, Vandel P, Zullino DF, Eap CB, Brawand-Amey M, Baumann P (2002) Carbamazepine augmentation in depressive patients non-responding to citalopram: A pharmacokinetic and clinical pilot study. European Neuropsychopharmacology 12:255-260
125. Szymura-Oleksiak J, Wyska E, Wasieczko A (2001) Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression. Psychopharmacology 154:38-42
126. Takahashi H, Yoshida K, Higuchi H, Shimizo T (2001) Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: Two case reports. Clin Neuropharmacol 24:358-360
127. Taylor D (1997) Pharmacokinetic interactions involving clozapine. Brit J Psychiatry 171:109-112
128. Tiihonen J, Vartiainen H, Hakola P (1995) Carbamazepine-induced changes in plasma levels of neuroleptics. Pharmacopsychiatry 28:26-28
129. Turnheim K (2004) Arzneimittelwechselwirkungen mit Antiepileptika. Wien Klin Wochenschr 116:112-118
130. van Wattum PJ (2001) Valproic acid and risperidone. J Am Acad Child Adolesc Psychiatry 40:866-867
131. Vercueil L, Adriantseheno LM, Hirsch E (1998) Surdosage en carbamazepine aprs administration d'un comprimá de sertraline: Relation au syndrome sérotonergique? Thérapie 53:502-504
132. Vincent FM (1980) Phenothizine-induced Phenytoin intoxication. Annals of Internal Medicine 93:56-57
133. Vitiello B (2001) Valproic acid and risperidone. J Am Acad Child Adolesc Psychiatry 40:867
134. Wiklander B, Danjou P, Rolan P, Tamin SK, Toon S (1995) Evaluation of the potential pharmacokinetic interaction of venlafaxine and carbamazepine. European Neuropsychopharmacology 5:310-311
135. Wirshing WC, Ames D, Bisheff S, Pierre JM, Mendoza A, Sun A (1997) Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatment. J Clin Psychopharmacol 17:120-121
136. Wong SL, Cavanaugh J, Shi H, Awni WM, Grannemann GR (1996) Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics. Clinical Pharmacology & Therapeutics 60:48-53
137. Wong YWJ, Yeh C, Thyrum PT (2000) The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 21:89-93
138. Woods DJ, Coulter DM, Pillans P (1994) Interaction of phenytoin and fluoxetine. New Zealand Medical Journal 107:19